Published date: 3 October 2016

Last edited date: 18 November 2016

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Closing: 17 October 2016

Contract summary

Industry

  • Health services - 85100000

  • Community health services - 85323000

Location of contract

South East

Value of contract

£1

Procurement reference

P2016-011-2

Published date

3 October 2016

Closing date

17 October 2016

Contract start date

1 December 2016

Contract end date

30 September 2019

Contract type

Service contract

Procedure type

Other:

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

Yes

Description

Procurement of a Primary Care Service for the provision of anticoagulation treatment under an Any Qualified Provider (AQP) approach, this is a further window/opportunity following the original AQP procurement advertised in June 2016. The Commissioner is NHS Canterbury and Coastal CCG as Lead Commissioner, NHS Ashford CCG as Associate Commissioner. The Commissioner is supported in this project by NHS South East CSU (SECSU) and its procurement partner NHS Commercial Solutions (NHSCS), which is managing this procurement.


The overall aim of the service is to provide eligible patients with access to an integrated out of hospital anticoagulation service for medication (warfarin and acencoumarol) that requires International Normalized Ratio (INR) monitoring. This service will provide the monitoring required and provide prescriptions for the medication.


The contractor will provide on-going monitoring for patients who have already been initiated on warfarin treatment and who have the following diagnoses:
• non-valvular and valvular atrial fibrillation (CHA2DS2VASc ≥1)
• a confirmed diagnosis of Deep Vein Thrombosis (DVT) or Pulmonary Embolism (PE), who have been discharged from a recognised diagnostic service and have been referred by a specialist with a clear duration of treatment and INR target range specified.
• Stable mechanical valves.
• Other diagnoses where the specialist and contractor agree that ongoing monitoring in primary care is appropriate.


With this AQP approach all bidders who complete the accreditation process to (a) demonstrate capability and capacity to deliver the service and (b) accept the standard NHS contract terms and conditions and (c) accept the Commissioner's local tariff price will become qualified providers. All qualified providers will be offered the standard NHS contract with the same terms, conditions, and price. The contract will have no guaranteed minimum level of activity and no restricted maximum level of activity. Providers will be paid according to the actual activity level delivered.

More information

Previous notice about this procurement

Primary Care Service for the provision of Community Anti-Coagulation Treatment

  • Awarded contract
  • Published 20 June 2016

Attachments

Links

Additional text

This procurement is being conducted using the Bravo eSourcing portal. Details of how to register on Bravo and how to access the procurement within Bravo are in the attached document "How to apply". This procurement is identified on Bravo as project_1917 - EK CACS (Community anti-coagulation service) AQP itt_2224 - EK CACS AQP P2016-011-2

About the buyer

Contact name

Contact via Bravo eSourcing portal

Address

Contact via Bravo eSourcing portal
Contact via Bravo eSourcing port
CONTACT VIA BRAV
England

Email

NHSCS.commissioning@nhs.net

Website

https://commercialsolutions.bravosolution.co.uk/